1. Home
  2. ARTL vs GITS Comparison

ARTL vs GITS Comparison

Compare ARTL & GITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artelo Biosciences Inc.

ARTL

Artelo Biosciences Inc.

HOLD

Current Price

$1.42

Market Cap

2.6M

Sector

Health Care

ML Signal

HOLD

GITS

Global Interactive Technologies Inc.

HOLD

Current Price

$0.80

Market Cap

2.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARTL
GITS
Founded
2011
2018
Country
United States
South Korea
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6M
2.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ARTL
GITS
Price
$1.42
$0.80
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$30.00
N/A
AVG Volume (30 Days)
108.0K
54.4K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,867.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.15
$0.66
52 Week High
$28.60
$5.06

Technical Indicators

Market Signals
Indicator
ARTL
GITS
Relative Strength Index (RSI) 40.55 36.89
Support Level $1.48 $0.79
Resistance Level $1.82 $0.86
Average True Range (ATR) 0.16 0.09
MACD 0.04 0.03
Stochastic Oscillator 39.55 48.50

Price Performance

Historical Comparison
ARTL
GITS

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About GITS Global Interactive Technologies Inc.

Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.

Share on Social Networks: